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Minimalistic peptidic scaffolds harbouring an
artificial carbene-containing amino acid modulate
reductase activity†
Karst Lenzen,‡ Matteo Planchestainer,‡ Isabelle Feller, David Roura Padrosa,
Francesca Paradisi * and Martin Albrecht *
Inspired by the boom of new artificial metalloenzymes, we devel-
oped an Fmoc-protected histidinium salt (Hum) as N-heterocyclic
carbene precursor. Hum was placed via solid-phase peptide synth-
esis into short 7-mer peptides. Upon iridation, the metallo-peptidic
construct displayed activity in catalytic hydrogenation that outper-
forms small molecule analogues and which is dependent on the
peptide sequence, a typical feature of metalloenzymes.
The implementation of abiotic reactivity is considered to be one
of the most powerful strategies to broaden the toolbox of
biocatalysis.1 Non-natural transformations have been evoked,
for example, by directed evolution of natural metalloenzymes,
e.g. silylation with P450,2 by site directed mutagenesis
using (non-)natural amino acids,3 or by the incorporation of a
synthetic co-factor with a specific abiotic transition metal
center.4 This latter approach also allowed for incorporating
N-heterocyclic carbene (NHC) metal complexes into a protein
scaffold to produce evolvable artificial metalloenzymes that
catalyze olefin metathesis5 and hydrogenation.6
The use of N-heterocyclic carbene complexes to generate
minimalistic peptidic scaffolds displaying pseudo-enzymatic
activity: on one handside, NHCs have been standing out as
facilitator ligands in homogeneous catalysis7 and, on the other,
the side chain of histidine (His) provides the imidazole skele-
ton of NHCs and may therefore potentially bind a metal center
via classical N- or carbenic C-coordination.8 Previous work in
our group9 and others10 has shown that histidylidene com-
plexes are accessible, though incorporation into oligopeptides
required the introduction of an external NHC ligand.11
Considering the potential existence of carbenes in bio-
logical systems,2,3,8 and the possibility to incorporate
carbene-precursors in amino acids, we got intrigued to broaden
the scope by incorporating a carbene precursor into peptide
sequences and test the effect of different amino acid scaffolds
in catalysis. Therefore, the histidinium salt Fmoc-Hum-OH
(Scheme 1, abbreviated one letter code Ḧ) was designed with
a Fmoc protection group which allows for use in standard solid-
phase peptide synthesis (SPPS). Here, we show a simple series
of palindromic heptapeptides with which we probe the effec-
tiveness of coupling Hum in SPPS. Iridium was chosen as a
metal center for binding the carbene, as Ir–NHC complexes
have shown high activity in a range of catalytic applications,12
moreover, the Ir–CNHC bond is exceptionally stable under acidic
and basic conditions.13 This approach furnished metallo-
peptides with pseudo reductase activity, demonstrated in the
hydrogenation of acetophenone as model reaction.
The artificial amino acid Hum as NHC precursor was prepared
by methylation of Boc-His-OH, which yielded Boc-Hum-OMe in
good yields (Scheme 1).14 Sequential protecting group modifica-
tions gave Fmoc-Hum-OH over 4 steps in 47% overall yield.
A direct Boc/Fmoc exchange after ester hydrolysis via the unpro-
tected Hum gave only traces of the desired product in a complex
mixture. Fmoc-Hum-OH was analyzed by NMR spectroscopy, MS,
and its purity confirmed by microanalysis. Diagnostic NMR signals
include the two singlets due to chemically distinct N–CH3 groups
(dH 3.51, 3.48) and two aromatic resonances at dH 6.87 and 8.31 for
Hd and He, respectively. Derivatization of Fmoc-Hum-OH via
Hum–OMe with (S)-Mosher’s acid indicated at least 95% retention
of enantiopurity (ESI†) and negligible racemization during the Boc
deprotection step of the phenacyl (PAc) protected ester group.15
Fmoc-Hum-OH has the appropriate functionalization for
application in SPPS and has been used to prepare a set of
palindromic heptapeptides AXAḦAXA with varying amino acids
X in the 2- and 6-position and Hum (Ḧ) in the central position
(Scheme 2). To test the compatibility of the Hum towards
coordination of metals in the presence of different functional
groups, X was permuted with all 20 natural amino acids. This
afforded 20 heptapeptides that were unfunctionalized neutral
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(X = Gly), hydrophobic (X = Ala, Val, Pro, Ile, Leu, Met), aromatic
(X = Phe, Tyr, Trp), positively charged (X = His, Arg, Lys),
negatively charged (X = Asp, Glu) or polar uncharged (X = Ser,
Asn, Tyr, Gln, Cys). While coupling of the first three amino
acids on the Wang resin followed standard procedures,16
coupling of Fmoc-Hum-OH required longer reaction times
(5 vs. 1–2 h) to reach completion (TNBS control). Also, coupling
of the subsequent Ala was performed twice to reach optimal
results. Subsequent introduction of X and A proceeded again
according to standard protocols.
TFA-mediated cleavage of the heptapeptide followed by
revers-phase HPLC purification yielded the apo-peptides sub-
gram quantities (about 20 mg per 50 mg Wang resin with a
0.4–0.8 mmol g1 pre-loading). Identity and purity were analyzed
by high-resolution ESI-MS, LC–MS and NMR spectroscopy (†). For
example, for the sequence ASAḦASA with two Ser and Hum and
alternating Ala, 1H–1H COSY identified the Hum CaH-proton
as a distinct triplet at dH 4.61, which is well-separated from the
CaH-protons of the other amino acids (dH 4.18–4.35). The Hum Hd
and He appeared as singlets at dH 7.17 and 8.52 ppm, respectively.
The presence of just one set of signals in the 1H and 13C NMR
spectra indicate the presence of just one isomer, suggesting that
either the D-Hum epimer is not distinguishable by NMR analysis
(cf. Mosher acid analysis) or that only the L-enantiomer is incorpo-
rated into the peptide.
Installation of the catalytic iridium center was accomplished
on the resin-bound heptapeptide by treatment with Ag2O to
form the putative carbene silver intermediate, followed by
transmetalation with [IrCl2Cp*]2.§ After incubation for 24 h,
the metallopeptide was cleaved from the resin with TFA, a
procedure that is applicable because the Ir–CNHC bond is
remarkably stable under acidic conditions. While this proce-
dure was successful for most palindromic sequences, those
with X = Val, Trp, or His gave lower yields, the latter presumably
because of interference of the heteroaromatic side chain with
the metal center. Moreover, the procedure failed when Cys or
Met were used as amino acids, which was attributed to the
strong affinity of Ag to sulfur ligands and therefore a preferred
reactivity of Ag2O with these side chains rather than the Hum.
Analysis by LC–MS of crude samples after resin cleavage
revealed only partial metalation, which was attributed to partial
hydrolytic Ir–C bond scission in the resin cleavage step due to
the presence of TFA rather than to an incomplete metalation.
Revers phase HPLC purification yielded the pure peptidic
scaffolds AXAḦAXA–Ir (LC–MS). Analysis by HR-MS revealed a
most significant signal for [AXAḦAXA–Ir –2Cl]2+ for all peptides
except for the Lys-containing heptamer, for which z = 3 due to
the basic side chain (†). The NMR spectra of these systems were
consistently very broad, though they clearly revealed the Cp*
proton signals around 1.6 ppm in the correct integral ratio.
Depending on the amino acid sequence, this signal is split in
two or more different signals, which however coalesce to a
single resonance at 50 1C. Therefore, the different Cp* signals
were attributed to distinct rotamers that show restricted inter-
conversion due to the metal fragment bound to Hum, rather
than epimers.
Since NHC iridium complexes are established hydrogena-
tion catalysts, we investigated the activity of this minimalistic
peptidic scaffolds in catalytic hydrogenation in citrate buffer at
pH 3. All AXAḦAXA–Ir constructs showed activity in the hydro-
genation of acetophenone as model substrate, albeit without
any enantiomeric excess (ee o 3%). Reminiscent to metalloen-
zymes, the activity of the heptapeptide shows considerable
dependence on the type of amino acids in close proximity to
the active site (Table 1, entries 1–18). For example, there is an
order of magnitude difference between X = R (TOF = 3 h1) and
X = Y (TOF = 30 h1; entry 11 vs. 8).¶ Some general trends from
this initial activity screen can be deduced. For example, aro-
matic side chains (X = F, Y) have a positive effect on the catalytic
activity, possibly because of suitable interactions with the
Scheme 2 Solid-phase peptide synthesis (SPPS) of the palindromic AXA-
ḦAXA heptapeptide and iridation to form a mini-metalloenzyme with a
NHC iridium active site. Reagents and conditions: (i) piperidine in DMF; (ii)
Fmoc-Aaa-OH, oxyma, collidine, DIC in NMP; (iii) AcOAc in CH2Cl2,; (iv)
Ag2O, Me4NCl in CH2Cl2/MeCN; (v) [IrCl2Cp*]2 in CH2Cl2/MeCN; (vi) TFA
in H2O. X = permutation of all 20 natural amino acids.
Scheme 1 Synthesis of Fmoc-protected Hum (Ḧ). Reagents and condi-
tions: (i) MeI, MeCN, 40 C; (ii) LiOH, MeOH/H2O, r.t.; (iii) PAc-Br, KF, DMF,
r.t.; (iv) HCl, dioxane, then immediately FmocCl, Na2CO3, MeCN, r.t.; (v) Zn,
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substrate. Potentially coordinating side chains reduce the
activity (X = H, K) or induce an induction period (X = E, but
not D, probably because the additional CH2 group in E enables
metal binding). Bulkiness of the side chain has some inhibiting
effect (S vs. T, N vs. Q), yet this effect was not observed in
hydrophobic side chains. These variations indicate that these
mini scaffolds can be tailored despite their small size. More-
over, the oligopeptide backbone is highly relevant for the
catalytic activity as the iridium-complex 1 bound to protected
Hum or a simple NHC iridium analogue (2) showed much lower
activity and reached a modest o20% conversion after 24 h
(cf 490% conversion with selected mini scaffolds with X = A, F,
G, S, Y) under identical reaction conditions (entries 20 and 21,
Fig. 1, Fig. S1, ESI†). The metal precursor [IrCl2Cp*]2 does not
show any detectable activity (entry 19).
To shed some light on the structural implications imparted
by the variations in the amino acid sequence, molecular
dynamics simulations of all 18 catalytically active heptapep-
tides were performed (†). The peptides were modelled initially
with His rather than the Hum–Ir in central position. The Hum–
Ir was then constructed as a constrained entity based on
reported crystal structure data using the UCSF Chimera soft-
ware. The conformational changes of the metal-free heptapep-
tides in 20 ns intervals indicate that despite their short size,
most heptapeptides adopt stable secondary structures (Fig. S2–S4
and see also CD spectra in S5, ESI†).17 While neither the root mean
square deviation of the conformational changes of the heptapep-
tide nor the number of clusters from the simulations correlate
with the catalytic activity, the histidine exposure revealed a positive
correlation with the TOFmax (Fig. S6 and Table S1, ESI†). For
example, AYAHAYA with two Tyr adopts secondary structures in
which the central His is well-exposed for solvent and substrate
accessibility. Closer inspection of the structures indicates a con-
formationally stable interaction between one phenol side chain
and the central His unit, also when bound to Ir in the AYAḦAYA-Ir
variant (Fig. 2). Similar His/Tyr interactions have been noted
previously.18 The correlation between His exposure and catalytic
activity for subsets of the heptapeptides (Fig. S6, ESI†) constitutes a
key concept of metalloenzyme engineering and offers an attractive
approach for further optimization of the catalytic performance,
especially upon increasing the length of the peptide sequence.
In summary, a versatile pre-carbene amino acid was devel-
oped, and was incorporated into oligopeptides to generate
minimalistic protein-like assemblies containing a metal–car-
bene active site. The introduction of an Fmoc-protecting group
on the N-terminus of the amino acid allowed for the use of SPPS
as synthetic approach for de novo peptide synthesis. Metalation
was performed successfully with an Ir-precursor on the resin-
bound peptides, followed by cleavage of the organometallic
bioconjugate from the resin, which generated active scaffolds
for hydrogenation reactions. This system shows characteristics
which mimics natural enzymes including a direct dependence
of the catalytic activity on proximal amino acid side chains,
which provides opportunities for evolution. While the
Table 1 Catalytic hydrogenation of acetophenonea
Entry Category Xb TOFmax
c (h1) Conversiond (%)
1 Unfunctionalized G 20 95
2 A 17 91
3 V 18 86
4 Hydrophobic P 18 77
5 I 16 83
6 L 13 82
7 F 24 94
8 Aromatic Y 30 96
9 W 12 60
10 H n.d. o2
11 +Charge R 3 40
12 K 9 81
13 Charge D 17 80
14 E 17 78
15 Polar uncharged S 17 94
16 N 19 88
17 T 7 82
18 Q 10 70
19 [IrCl2Cp*]2 n.d. o2
20 Reference 1 2 18
21 2 1 19
a General reaction conditions: acetophenone (10 mmol), [Ir] (0.1 mmol, 1
mol%), citrate buffer pH 3/tBuOH (1 mL, 4 : 1 v/v), 40 1C, H2 atmosphere.
b X = M, C not evaluated since metalation did not proceed. c TOFmax
determined from the rate at the steepest section for each entry, n.d. not
determined. d Conversion determined by GC, all ee o 3%.
Fig. 1 Schematic of small molecule catalysts 1 and 2.
Fig. 2 Superimposition of most stable conformations deduced from
molecular dynamics simulation of representative heptapeptides AXAHAXA
containing a central His and X = Tyr, Ser, Gly, Val, and Arg from two
different angles (a and b). The phenol residue of Tyr remains in close
proximity of the His (see ESI† for time-deconvoluted movies of conforma-
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heptapeptide sequence is short to impose unique secondary
structures, molecular dynamics identified for some of the
peptide sequences clear energy minima. The established
potential of SPPS to prepare also longer structures and the
availability of mixed de-novo/ligation strategies offers
approaches to implement structural elements and to tailor
further the selectivity of this bio-inspired catalyst. A particularly
appealing aspect of the concept disclosed here is the opportu-
nity to combine an enzymatic scaffold with carbene complexes
and their vast array of catalytic applications. This combination
considerably expands the toolbox of biocatalysis and allows to
design systems for abiotic transformations.
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V. Lebrun, R. Reuter, V. Köhler, J. C. Lewis and T. R. Ward, Chem.
Rev., 2018, 118, 142–231; H. M. Key, P. Dydio, D. S. Clark and
J. F. Hartwig, Nature, 2016, 534, 534–537.
5 C. Mayer, D. G. Gillingham, T. R. Ward and D. Hilvert, Chem.
Commun., 2011, 47, 12068–12070; V. Köhler, Y. M. Wilson,
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